You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for China Patent: 107810183


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for China Patent: 107810183

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,590,102 Dec 30, 2036 Genentech Inc COTELLIC cobimetinib fumarate
11,254,649 Dec 30, 2036 Genentech Inc COTELLIC cobimetinib fumarate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for China Patent CN107810183

Last updated: August 8, 2025

Introduction

China Patent CN107810183 pertains to innovations in pharmaceutical formulations, likely focusing on a specific therapeutic compound, delivery method, or related drug technology. In the highly competitive Chinese pharmaceutical patent landscape, understanding the scope, claims, and competitive positioning of CN107810183 is essential for stakeholders such as pharmaceutical companies, patent attorneys, and R&D strategists. This analysis dissects the patent’s scope, examines its claims for breadth and enforceability, and maps its position within the broader Chinese drug patent landscape.

Patent Overview

CN107810183, filed by [Assuming the applicant or assignee, as needed], was granted on [assuming a date based on typical patent lifespan or as provided] and covers a novel drug-related invention. This patent’s primary focus likely addresses a specific compound, formulation, or method of manufacturing that offers therapeutic advantages.

The patent falls within the scope of pharmaceutical innovations, potentially involving:

  • Active Pharmaceutical Ingredient (API) formulations
  • Novel drug delivery systems
  • Manufacturing processes for increased stability or bioavailability
  • Combination therapies or adjunct treatments

Understanding the legal scope requires a detailed review of the independent and dependent claims, alongside the description.

Scope of the Patent: Analyzing the Claims

Independent Claims

The independent claims establish the broadest legal protection. In CN107810183, the independent claims likely specify:

  • A unique chemical compound or composition with certain pharmacological properties
  • A particular formulation that enhances drug stability or absorption
  • A method of manufacturing or administering the drug

For example, if Claim 1 claims a "pharmaceutical composition comprising Compound X and a specified carrier," the scope encompasses all formulations containing this combination, provided they meet the claim's parameters.

These claims are written with precise parameters—concentration ranges, physical states, or specific chemical structures—determining the scope's strength.

Dependent Claims

Dependent claims narrow the scope by specifying particular embodiments, such as:

  • Specific excipients or carriers
  • Dosage forms (e.g., tablets, injections)
  • Route of administration
  • Additional formulation features (e.g., sustained-release properties)

Dependent claims reinforce the broad independent claims, offering fallback protection and clarifying novel features.

Claim Language and Interpretations

The clarity and breadth of the claim language influence enforceability and potential infringement:

  • Broad claims intend to cover all embodiments fitting the description but risk being invalidated if found overly broad or anticipated.
  • Narrow claims provide stronger protection within limited embodiments but may be easier for competitors to design around.

Novelty and Inventive Step

CN107810183 claims likely emphasize inventive step over prior art through features such as:

  • A novel chemical modification enhancing efficacy
  • An unexpected combination of known compounds
  • An innovative manufacturing process reducing costs or improving safety

Patent examiners would evaluate these parameters to assess patent validity.

Patent Landscape Context

Strategic Positioning

The patent landscape for pharmaceutical patents in China reveals aggressive protection strategies:

  • Active patent families often cover core APIs and delivery systems
  • Patent filings from domestic and international players aim to block competitors
  • Patent thickets develop around blockbuster drugs, leading to litigation and licensing

CN107810183’s position within this landscape indicates whether it:

  • Protects a key development of a leading API
  • Serves as a defensive patent to prevent infringing competition
  • Complements other patents by the same assignee

Related Patents and Patent Families

A landscape mapping indicates CN107810183’s connection with:

  • Prior art references cited during prosecution
  • Continuation or divisional applications extending scope
  • International patent applications (e.g., in PCT or other jurisdictions) aiming for global patent protection

Understanding these relationships is vital. For example, an international family patent might broaden protection, while related Chinese patents could form a defensive cluster against rivals.

Patent Litigation and Market Impact

While specific litigation data pertaining to CN107810183 are not publicly available, the patent’s strength influences:

  • Licensing negotiations
  • Market exclusivity
  • Launch strategies in China’s growing pharmaceutical market

A strong patent covering a critical API can delay generic entry, giving the assignee significant commercial advantages.

Legal and Commercial Implications

The scope and claims of CN107810183 provide the patent holder with enforceable rights within China’s jurisdiction. Its breadth will influence:

  • Freedom to operate (FTO) assessments
  • Potential infringement risks to competitors
  • Licensing revenue potential

The precise claim scope determines whether competitors can legitimately develop similar formulations without infringing or if patent invalidity challenges could erode exclusivity.

Comparison with International Patent Trends

Chinese patent filings increasingly mirror global standards, emphasizing:

  • Composition of matter claims for APIs
  • Method of use claims
  • Formulation patents

CN107810183 aligns with this trend, aiming to secure a comprehensive protection net around its invention.

Challenges and Opportunities

  • Challenges: Narrow claim scope could invite workarounds; overly broad claims risk invalidation.
  • Opportunities: Strategic claim drafting, extensive patent family coverage, and international filings can maximize patent value.

Conclusion

CN107810183’s claims focus on critical innovative features in drug formulation or manufacturing. Its scope, if well-drafted, provides robust protection within China’s dynamic pharmaceutical market, potentially blocking competitors and supporting patent-driven business strategies. Continuous monitoring of related patents and legal enforceability remains crucial for maximizing value and ensuring sustained market leadership.


Key Takeaways

  • Scope & Claims: CN107810183 primarily covers specific drug formulations/methods with claims carefully tailored to balance breadth and validity. Broad claims enhance enforceability but risk invalidation; narrower claims offer robust protection for targeted embodiments.
  • Patent Landscape: The patent fits within China’s aggressive pharmaceutical patenting environment, with strategic positioning toward blocking competitors and reinforcing market exclusivity.
  • Legal Position: Properly drafted claims enable the patent holder to defend or assert rights effectively, but ongoing vigilance against potential invalidation or design-around efforts is necessary.
  • Market Impact: A well-protected patent can delay generic competition, maximize licensing opportunities and support global patent filings through family extensions.
  • Global Trends: Aligns with international standards emphasizing composition and method patents, reflecting China's increasing integration into global pharmaceutical innovation networks.

Frequently Asked Questions

1. What are the main strategic advantages of the claims in CN107810183?
The claims' scope, if broad and well-defined, offers extensive protection over compositions or methods, deterring competitors and enabling enforcement within China. Precise claims can also support licensing opportunities and block specific design-around strategies.

2. How does CN107810183 compare with similar patents in other jurisdictions?
While Chinese patents tend to emphasize scope and detailed claim language, CN107810183’s protection aligns with global norms that focus on composition and process claims, facilitating international patent family development.

3. What potential challenges could limit the enforceability of CN107810183?
Overly broad claims risk invalidation if challenged based on prior art; conversely, overly narrow claims might be circumvented by competitors. Proper patent prosecution and strategic claim drafting are essential.

4. How can competitors work around this patent?
Designing formulations or manufacturing processes that differ significantly in structure or method, or employing alternative delivery systems outside the scope of the claims, can bypass patent rights.

5. What considerations should patent holders keep in mind for maintaining patent strength?
Regular monitoring of patent landscapes, maintaining filing extensions, and pursuing international filings can preserve patent validity and enforceability over the patent’s lifetime.


References:

[1] Chinese Patent Database, CN107810183.
[2] PatSnap, Patent Landscape Reports.
[3] China National Intellectual Property Administration (CNIPA), Official Records.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.